Epigenetic Reprogramming in Cancer
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
The demonstration of induced pluripotency and direct lineage conversion has led to remarkable insights regarding the roles of transcription factors and chromatin regulators in mediating cell state transitions. Beyond its considerable implications for regenerative medicine, this body of work is highly relevant to multiple stages of oncogenesis, from the initial cellular transformation to the hierarchical organization of established malignancies. Here, we review conceptual parallels between the respective biological phenomena, highlighting important interrelationships among transcription factors, chromatin regulators, and preexisting epigenetic states. The shared mechanisms provide insights into oncogenic transformation, tumor heterogeneity, and cancer stem cell models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was demonstrated that ipilimumab induces the expression of EZH2, a key epigenetic enzyme that plays an important role in cellular plasticity (115-118).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [117]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Expression of a single transfected cDNA converts fibroblasts to myoblasts
Davis, R. L., Weintraub, H., & Lassar, A. B. (1987) · Cell · doi:10.1016/0092-8674(87)90585-x · Cited by 3,385
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Cited by
Items 601–700 of 702
Carlberg, C., & Molnár, F. (2019) · Springer eBooks · doi:10.1007/978-3-030-22907-8_8 · Cited by 1
Epigenetic processes–driven disorders and therapeutics
Mohan, V., Thumoju, S., & Mohiuddin, M. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-21863-7.00001-9 · Cited by 1
Carving a therapeutic niche for metastatic cancer: Opportunities and challenges
Garimella, S. V., Roy, R., Gampa, S. C., & Pandrangi, S. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13209-4.00023-4 · Cited by 1
12 Heredity in the Epigenetic Era: Are We Facing a Politics of Reproductive Obligations?
Crawford, M. (2016) · BRILL eBooks · doi:10.1163/9789004315723_014 · Cited by 1
“Indeed, altered imprinting is a major new subject in the study of cancer progression and treatment (Blancafort, Jin, and Frye 2013, Suva, Riggi, and Bernstein 2013, Wang and Shang 2013).”
BackgroundLe facteur nétrine-1 régule la reprogrammation cellulaire vers l’état pluripotent
Mehlen, P., & Lavial, F. (2016) · médecine/sciences · doi:10.1051/medsci/20163203005 · Cited by 3
Costa, E., Sousa, A., Cabrita, A., Reis, C. P., & Figueiredo, I. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820016-2.00012-4 · Cited by 2
Zhao, W., Rong, Z., Wang, W., Li, S., Lu, Y., Cao, L., Zhang, L., Yang, K. G., Deng, K., Yang, C., et al. (2020) · Epigenomics · doi:10.2217/epi-2019-0142 · Cited by 1
Preventing phenotypic plasticity in cancer to mitigate therapy resistance
Coatham, M. L., Jewer, M., & Postovit, L.-M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821310-0.00002-4 · Cited by 1
Majumder, D. (2022) · Current Cancer Therapy Reviews · doi:10.2174/1573394718666220517112049 · Cited by 1
HUMANS, ANIMALS, AND PETRI DISHES: BIOMEDICAL MODELING BETWEEN EXPERIMENTATION AND REPRESENTATION
Germain, P. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/germain-pierre-luc_phd2014-03-25 · Cited by 2
Dhodapkar, M. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.17005-5 · Cited by 1
Identifying Epigenetic Signature of Breast Cancer with Machine LearningPreprint
Vaysburd, M. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1910.06899 · Cited by 1
Saygılı, G., Türktaş, M., Gürcan, C., Delogu, L. G., & Yılmazer, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.18.500480 · Cited by 1
“For example, several groups have tried to reprogram cancer cells via different protocols including the use of embryonic microenvironment, nuclear transfer or transfection with the reprogramming factors resulting in altered tumorigenicity 13–18 .”
BackgroundLaguna, T., Piette, O., Garranzo, M., de Cedrón, M. G., de Molina, A. R., & Pau, E. C. D. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.19.549686 · Cited by 1
“We generated a new classification of COAD tumors based on variability of epigenomic data, as it has been related with cell lineages and tumoral activity (Suvà et al. 2013; Costa et al. 2023; Kim and Costello 2017).”
MethodXu, Y., Cui, J., & Puett, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1381-7_1
Transcriptional and Epigenetic Regulation of Epithelial-Mesenchymal Transition
Tan, E. (2013) · DiVA (Digitala Vetenskapliga Arkivet)
SAGA, TFIID and regulation of transcription through chromatin
Schram, A. W. (2013) · Utrecht University Repository (Utrecht University)
Preclinical Liver Bud Engineering towards Clinical Target for Liver Diseases
Giri, S., & Bader, A. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.02.151
The role of miR-34 in epithelial to mesenchymal transition and metastasis of colorectal cancer
Siemens, H. (2014) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16641
Epigenetic alterations in sporadic and familial cancers
Joensuu, E. I. (2015) · Helda - University of Helsinki Institutional Repository
SOX7 is downregulated and functions as a tumor suppressive transcription factor in breast cancer
Stovall, D. B. (2014) · WakeSpace Scholarship (Wake Forest University)
Integrative genomic and clinical analysis of follicular lymphoma
Brodtkorb, M. (2014) · NORA - Norwegian Open Research Archives
Clinical Applications of Induced Pluripotent Stem Cells in Cancer
Fernandez, T. D. S., Mencalha, A. L., & Fernandez, C. D. S. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-33270-3_7
Barutcu, A. R. (2016) · eScholarship@UMassChan · doi:10.13028/m2t01z
Neoplasia of the Gastrointestinal Tract
Margalit, O., & DuBois, R. N. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch31
Mechanism of action of ID4 as a tumor suppressor
Komaragiri, S. K. (2016) · Atlanta University Center Robert W. Woodruff Library (Atlanta University Center Robert W. Woodruff Library)
Nanoscale Cancer Therapeutics: Advances, Hurdles and Hopes
Moffatt, S. (2017) · International Journal of Nano Studies & Technology · doi:10.19070/2167-8685-si04002
“Cancer constitutes many heterogeneous diseases [1] having varied genetic and epigenetic abnormalities [2, 3] afflicting millions of people globally.”
BackgroundEpigenetic Signature in Breast Carcinoma, a Hidden Language to Dictate Against Genomic Insults
Kumar, A., Jahagirdar, D., Purohit, S., & Sharma, N. K. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-3085-5.ch002
ANALYSIS OF GENE METHYLATION SHOX2, TGFBR1, MIR-375 IN DIFFERENT TYPES OF LUNG CANCER
Ходырев, Д. С., Kulagina, N. S., Brovkina, O., Pokrovsky, V. E., Gordiev, M., Степановна, К. А., Nikitin, A. G., & Averyanov, A. (2016) · Journal of clinical practice · doi:10.17816/clinpract7427-33
Uchiumi, F., Arakawa, J., Takihara, Y., Akui, M., Hamada, H., & Tanuma, S. (2018) · InTech eBooks · doi:10.5772/intechopen.71095 · Cited by 1
“It has been hypothesized that epigenetic and/or transcriptional changes play a role in determining the chromatin state in tumor cells [97].”
BackgroundDávila, C. K. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2019.tde-07052019-103413 · Cited by 2
How far advanced the application of NGS technology to head and neck cancer?
Masuda, M. (2019) · Toukeibu Gan · doi:10.5981/jjhnc.45.343
Li, S.-L., Li, Y., Ye, Y., Yuan, X., Wang, J., & Yan, H. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.15.204024
Chromatin plasticity in pluripotent and cancer stem cells
Biran, A., & Meshorer, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814085-7.00009-x · Cited by 1
Naked mole rat iPSCs and their noncanonical features: a novel tool for aging research
Lee, S., Mikhalchenko, A. E., & Gladyshev, V. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822228-7.00004-7
Ocsenas, O. (2020) · TSpace (University of Toronto)
Muthukrishnan, S. D., Kawaguchi, R., Nair, P., Prasad, R., Qin, Y., Johnson, M., VanderVeer-Harris, N., Condro, M. C., Alvarado, A. G., Pham, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.03.447005
“Radiated gliomaspheres exhibit increased chromatin accessibility and H3K27Ac in specific vascular gene regions Transition between cellular states requires epigenetic and transcriptional reprogramming driven by alterations in chromatin structure and accessibility (28,29).”
BackgroundEpigenetic regulation of the cell cycle & DNA-repair in cancer
Tallen, G. R. N., Yang, Y., & Riabowol, K. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00027-1
Contribution of Stemness-Linked Transcription Regulators to the Progression of Breast Cancer
Segura‐Bautista, D., Maya‐Núñez, G., Aguilar‐Rojas, A., Huerta‐Reyes, M., & Pérez-Solis, M. A. (2021) · Current Molecular Medicine · doi:10.2174/1566524021666211124154803
7267 函館市西部地区の町並み景観の変貌とその要因に関する研究 : -経年的追跡調査による- 2. 変貌の要因と景観誘導の可能性
森下, 満., 足達, 富., 野口, 孝., & 山下, 圭. (1992) · 学術講演梗概集. F, 都市計画, 建築経済・住宅問題, 建築歴史・意匠
Poot, R. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727776019.793555748
Muehlich, S., & Mittermeier, C. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733426316.793549086
Liu, Z., Sun, J., Li, C., Xu, L., & Liu, J. (2021) · Research Square · doi:10.21203/rs.3.rs-390556/v1
(2017) · Wiley-VCH eBooks · doi:10.1002/9783527698448.ch20
Precision Medicine Based on Next Generation Sequencing and Master Controllers
Dukleska, K., Yeo, C. J., Pishvaian, M. J., & Brody, J. R. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_71-1
Faculty Opinions recommendation of Epigenetic plasticity and the hallmarks of cancer.
Copeland, R. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727820917.793555741
Contributions of stochastic events to biological evolution and cancer
Anderson, K. M., Rubenstein, M., Guinan, P., & Mk, P. (2015) · Journal of Cancer Research & Therapy · doi:10.14312/2052-4994.2015-15 · Cited by 1
Tan, Q., Cai, J., Peng, J., Hu, C., Wu, C., & Liu, H. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02641-8 · Cited by 1
Editorial: Mechanisms guarding the genome
Brown, J. A. L., Bourke, E., Hancock, W. W., & Richard, D. J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.974545
Alexeeva, M., Roalsø, M. T. T., & Søreide, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00027-x
Modulation of DNA/RNA Methylation by Small-Molecule Modulators and Their Implications in Cancer
Verma, A., Sinha, A., & Datta, D. B. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_17
Cell fate determination and lineage plasticity in prostate cancer
Gao, D. (2023) · Asian Journal of Andrology · doi:10.4103/aja20231
Schulz, W. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-16286-2_8
Penter, L., Gohil, S. H., Lareau, C. A., Ludwig, L. S., Parry, E. M., Huang, T., Li, S., Zhang, W., Livitz, D. G., Leshchiner, I., et al. (2023) · doi:10.1158/2159-8290.c.6549383.v1
Epigenetic modification: key regulator of reprogramming in cancer stem cells
Palol, V. V., Saravanan, S. K., Chinnadurai, R. K., & Subramanyam, V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13212-4.00017-9
Schulz, W. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-42806-7_8
Liu, P., Zhang, J., Du, D., Zhang, D., Jin, Z., Qiu, W., Zhou, X., Dong, S., Zhou, M., Zhao, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14752231
Liu, P., Zhang, J., Du, D., Zhang, D., Jin, Z., Qiu, W., Zhou, X., Dong, S., Zhou, M., Zhao, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14752228
Liu, P., Zhang, J., Du, D., Zhang, D., Jin, Z., Qiu, W., Zhou, X., Dong, S., Zhou, M., Zhao, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14752234
Lim, Z.-F. (2024) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.12594 · Cited by 1
A Brief Conceptual History of Epigenetics, and More Besides
Pocheville, A. (2025) · Wiley eBooks · doi:10.1002/9781394372683.ch1
Liu, H., Zeng, L., Wang, C., Chen, Y., Li, L., Liu, Z., Wang, H., & Fu, R. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70597
Fork Reversal Safeguards Epigenetic Inheritance during DNA Replication Under StressPreprint
Wu, Q., Zhou, C., Dou, Y., Martin, N. I., Gwit, M., Lee, T.-H., Hedglin, M., Chen, R., Zhu, K., Zhang, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.21.677631 · Cited by 1
Dhodapkar, M. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00513-5
Neth, B. J., Zhao, J., & Nead, K. T. (2025) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2025.2587282
“Complex biological factors including progressive gene mutations, chromatin remodeling, and cell-cell interactions drive intratumorally heterogeneity and the emergence of subclones with different genotypic and phenotypic features (Suva et al., 2013).”
Variability in natural invasion of tumor cells patterns in human glioblastoma
Kumari, D., Chaudhary, P., Janmeda, P., & Kumar, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33910-3.00003-0
Diagnostic and prognostic value of polygene methylation detection in ascites
Ma, Y., Wang, X., & Du, Y. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1680036
“DNA methylation markers have great potential for diagnosing cancer for several reasons: 1) Aberrant DNA methylation is a frequently observed characteristic of cancer cells (Jones, 2012; Baylin and Jones, 2011; Shen and Laird, 2013; Vogelstein et al., 2013; Suva et al., 2013).”
Liu, Z., Sun, J., Li, C., Xu, L., & Liu, J. (2021) · Figshare · doi:10.6084/m9.figshare.16944432
Liu, Z., Sun, J., Li, C., Xu, L., & Liu, J. (2021) · Figshare · doi:10.6084/m9.figshare.16944426
Tan, Q., 蔡净亭, Peng, J., Hu, C., Wu, C., & Liu, H. (2022) · Figshare · doi:10.6084/m9.figshare.20208262
Chen, Y.-H., Chen, C.-H., Chien, C.-Y., Su, Y.-Y., Luo, S.-D., & Li, S.-H. (2021) · Figshare · doi:10.6084/m9.figshare.16551177
Liu, Z., Sun, J., Li, C., Xu, L., & Liu, J. (2021) · Figshare · doi:10.6084/m9.figshare.16944429
Giordano, F., Paolì, A., Forastiero, M., Marsico, S., Amicis, F. D., Marrelli, M., Naimo, G. D., Mauro, L., & PANNO, M. L. (2024) · Figshare · doi:10.6084/m9.figshare.26572531
Liu, Z., Sun, J., Li, C., Xu, L., & Liu, J. (2021) · Figshare · doi:10.6084/m9.figshare.16944435
Bever, K. M., Thomas, D. L., Zhang, J., Rivera, E. A. D., Rosner, G. L., Zhu, Q., Nauroth, J. M., Christmas, B. J., Thompson, E. D., Anders, R. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13698350
Liu, P., Zhang, J., Du, D., Zhang, D., Jin, Z., Qiu, W., Zhou, X., Dong, S., Zhou, M., Zhao, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14752225
Giordano, F., Paolì, A., Forastiero, M., Marsico, S., Amicis, F. D., Marrelli, M., Naimo, G. D., Mauro, L., & PANNO, M. L. (2024) · Figshare · doi:10.6084/m9.figshare.26572528
Liu, Z., Sun, J., Li, C., Xu, L., & Liu, J. (2021) · Figshare · doi:10.6084/m9.figshare.16944438
PR inhibition stimulates G6PD expression to enhance malignancy in luminal breast cancer
Jeong, J. W., Lee, J., Bae, S. J., Cha, Y. J., Fang, S., Lee, H., & Ahn, S. G. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08365-7 · Cited by 1
“1.0) [35].”
Influentialİskender, B., Sarıhan, M., Barlak, B. S. R., Akpinar, G., & Kasap, M. (2026) · BMC Cancer · doi:10.1186/s12885-026-15634-x
“Reprogramming cancer cells is challenged by variable reprogramming efficiency arising from patient and tumour heterogeneity, tumour-associated DNA methylation and epigenetic barriers [11, 66].”
Gutiérrez-Pajares, J. L., Gómez-Betancur, I., & León, F. (2026) · Scientia Pharmaceutica · doi:10.3390/scipharm94010018
“This process occurs naturally during early embryonic development and in the formation of germ cells, where it resets the epigenetic landscape to a pluripotent state, allowing for proper development and differentiation [65].”
Chen, Y., Ma, Y., Zhao, G., Li, J., & Zhang, G. (2026) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s589185
“32 The observed correlation between copy number gain and high expression suggests that genomic amplification may partially contribute.”
Frankhouser, D. E., Yin, H. H., Belury, M. A., Newman, J. W., & Yee, L. D. (2026) · medRxiv · doi:10.64898/2026.03.18.26348746
Analyse génomique intégrée du cancer colique et impact thérapeutique
Laibe, S. (2013) · theses.fr (ABES) · doi:10.70675/adb95537z18c3z48c1zb2aaz2c78f03f4598
Alagarswamy, K. (2018) · Institutional Repositories DataBase (IRDB) · doi:10.20776/105862
Functional analysis of the proliferation antigen, KI-67 roles in cancer
Mrouj, K. (2018) · theses.fr (ABES) · doi:10.70675/66203ba0zb848z43f0za8d6zcda2bc074cbc · Cited by 1
Etude de la méthylation de l’ADN dans l’agressivité du mélanome cutané
Carrier, A. (2016) · theses.fr (ABES) · doi:10.70675/2901fdcfz8ddaz413ez9d43zf6e496971d08
Contrôle épigénétique de la biologie des lymphocytes T CD4
Malbec, A. (2018) · theses.fr (ABES) · doi:10.70675/6286d187zb91fz4014z9075z77e8f3c56b09
Boiteux, E. L. (2019) · theses.fr (ABES) · doi:10.70675/fd2f33cazc6a6z47b4z8258zac9ac2e67e38
Epigenome deregulation in Epstein Barr virus-induced oncogenic B cell transformation
Manara, F. (2023) · theses.fr (ABES) · doi:10.70675/fc1b53f0zc055z4a6cz85ddza2fd23e94768
Oncofetal Biology: From Fundamental Mechanisms to Emerging Therapeutic Opportunities
Liu, Y., Niu, K., Kong, Q., & Gao, S. (2026) · MedComm – Oncology · doi:10.1002/mog2.70071 · Cited by 1
Neurodevelopmental Blueprint in Gliomas: Toward an Ontogenetic Multimodal Integrated Therapy
Padevit, L., Weiß, T., Vasella, F., Neidert, M. C., Serra, C., Krayenbühl, N., Zadeh, G. M., Weller, M., Regli, L., & Akeret, K. (2026) · Journal of Clinical Oncology · doi:10.1200/jco-25-02798
BindingDB Entry 50011206: Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors.
BindingDB (2021) · UC San Diego · doi:10.7270/q22n55vz
Rybak, A. P. (2013) · MacSphere (McMaster University) · doi:10.71548/8413
Metadata
- Authors
- Suvà, M. L., Riggi, N., & Bernstein, B. E.
- Affiliations
- Broad Institute (US)
- Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
- Corresponding author
- Suvà, Mario L.
- Bernstein, Bradley E.
- Venue
- Science
- Published
- 2013-03-29
- Volume
- 339
- Issue
- 6127
- Pages
- 1567-1570
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3821556
- OpenAlex
- W2090757807
- Cited by
- 706
- References
- 64
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 19 · 2023: 40 · 2022: 34 · 2021: 61 · 2020: 62 · 2019: 48 · 2018: 58 · 2017: 72 · 2016: 67 · 2015: 76 · 2014: 85 · 2013: 43
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of Environmental Health Sciences (U01ES017155)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- epigenetic reprogramming, cancer, induced pluripotency, transcription factors, chromatin regulators, oncogenic transformation, tumor heterogeneity, cancer stem cells, cell state transitions
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Chromatin, Humans, Neoplasms, Transcription Factors, Neoplastic Stem Cells, DNA Methylation, Pluripotent Stem Cells, Epigenesis, Genetic, Mice, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.